Phase II study of oxaliplatin (OX), 5-fluorouracil (5-FU), and radiation therapy (RT) followed by gemcitabine (GEM) in patients with unresectable pancreatic cancer
Year: 2008
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: G. P. Kim, M. Haddock, N. R. Foster, J. Bollinger, P. J. Stella, J. W. Kugler, S. R. Alberts, J. Martenson
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2245615224